Ilya Goldshleger
CIK: 0001874147
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RxSight, Inc.
Discretionary Trading P&L
Holdings
Transaction History (74 total)
- Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
92.2K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
94K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
125K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
74K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
50K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
59.5K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock option (right to buy)
98.4K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
32.3K shares- - Sep 5, 2026RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
104.3K shares- - Sep 5, 2026RXST
RxSight, Inc.
Disposition(D)DirectStock Option (right to buy)
120K shares- - Sep 2, 2026RXST
RxSight, Inc.
Sale(S)Direct2K shares at avg. $6.96$14K - Aug 31, 2026RXST
RxSight, Inc.
Exercise(M)Direct5.4K shares- - Apr 17, 2026RXST
RxSight, Inc.
Exercise(M)Direct12.5K shares at avg. $4.13$52K - Feb 27, 2026RXST
RxSight, Inc.
Award(A)DirectRestricted Stock Unit
32.2K shares- - Sep 25, 2025RXST
RxSight, Inc.
Exercise(M)Direct15.1K shares at avg. $4.34$66K - Sep 25, 2025RXST
RxSight, Inc.
Exercise(M)Direct8.3K shares at avg. $4.13$34K - Feb 27, 2025RXST
RxSight, Inc.
Award(A)DirectStock Option (right to buy)
125K shares- - Nov 29, 2024RXST
RxSight, Inc.
Exercise(M)Direct3.1K shares at avg. $15.08$47K - Nov 29, 2024RXST
RxSight, Inc.
Sale(S)Direct3.1K shares at avg. $46.08$143K - Nov 26, 2024RXST
RxSight, Inc.
Sale(S)Direct3.1K shares at avg. $45.88$142K - Nov 26, 2024RXST
RxSight, Inc.
Exercise(M)Direct3.1K shares at avg. $15.08$47K - Nov 22, 2024RXST
RxSight, Inc.
Exercise(M)Direct3.1K shares at avg. $15.08$47K - Nov 22, 2024RXST
RxSight, Inc.
Sale(S)Direct3.1K shares at avg. $45.00$140K - Nov 18, 2024RXST
RxSight, Inc.
Sale(S)Direct33 shares at avg. $45.07$1K - Nov 18, 2024RXST
RxSight, Inc.
Sale(S)Direct3.1K shares at avg. $45.00$138K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 92,200 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 93,984 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 125,000 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 73,960 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 50,000 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 59,483 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock option (right to buy) | 98,367 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 32,258 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 104,347 | - | - | Direct |
| Sep 5, 2026 | RXST RxSight, Inc. | Disposition(D) Stock Option (right to buy) | 120,000 | - | - | Direct |
| Sep 2, 2026 | RXST RxSight, Inc. | Sale(S) | 2,041 | $6.96 | $14,205 | Direct |
| Aug 31, 2026 | RXST RxSight, Inc. | Exercise(M) | 5,370 | - | $0 | Direct |
| Apr 17, 2026 | RXST RxSight, Inc. | Exercise(M) | 12,489 | $4.13 | $51,580 | Direct |
| Feb 27, 2026 | RXST RxSight, Inc. | Award(A) Restricted Stock Unit | 32,218 | - | - | Direct |
| Sep 25, 2025 | RXST RxSight, Inc. | Exercise(M) | 15,096 | $4.34 | $65,517 | Direct |
| Sep 25, 2025 | RXST RxSight, Inc. | Exercise(M) | 8,349 | $4.13 | $34,481 | Direct |
| Feb 27, 2025 | RXST RxSight, Inc. | Award(A) Stock Option (right to buy) | 125,000 | - | - | Direct |
| Nov 29, 2024 | RXST RxSight, Inc. | Exercise(M) | 3,105 | $15.08 | $46,823 | Direct |
| Nov 29, 2024 | RXST RxSight, Inc. | Sale(S) | 3,105 | $46.08 | $143,078 | Direct |
| Nov 26, 2024 | RXST RxSight, Inc. | Sale(S) | 3,100 | $45.88 | $142,228 | Direct |
| Nov 26, 2024 | RXST RxSight, Inc. | Exercise(M) | 3,100 | $15.08 | $46,748 | Direct |
| Nov 22, 2024 | RXST RxSight, Inc. | Exercise(M) | 3,100 | $15.08 | $46,748 | Direct |
| Nov 22, 2024 | RXST RxSight, Inc. | Sale(S) | 3,100 | $45.00 | $139,500 | Direct |
| Nov 18, 2024 | RXST RxSight, Inc. | Sale(S) | 33 | $45.07 | $1,487 | Direct |
| Nov 18, 2024 | RXST RxSight, Inc. | Sale(S) | 3,067 | $45.00 | $138,015 | Direct |
1-25 of 74 transactions
About Goldshleger Ilya
Goldshleger Ilya (SEC CIK 0001874147) files insider reports with the SEC as Chief Operating Officer of RxSight, Inc. (RXST).
Signal8 holds 21 ownership filings by Goldshleger Ilya, all Form 4s, filed between Sep 18, 2024 and Sep 9, 2026. Those filings report 74 transactions, from Sep 17, 2024 to Sep 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Goldshleger Ilya's filings is in ALISO VIEJO, CA.
Recent filings by Goldshleger Ilya
- Sep 5, 2026: Disposition to issuer transaction of RXST derivative securities (Form 4, code D).
- Sep 5, 2026: Grant or award of RXST derivative securities (Form 4, code A).
- Sep 5, 2026: Disposition to issuer transaction of RXST derivative securities (Form 4, code D).
- Sep 5, 2026: Grant or award of RXST derivative securities (Form 4, code A).
- Sep 5, 2026: Disposition to issuer transaction of RXST derivative securities (Form 4, code D).
Other insiders filing for RxSight, Inc. (RXST)
- Weinberg Eric
- Wilterding Mark, Chief Financial Officer
- Kurtz Ronald M MD, Chief Medical Officer
- Mottiwala Aziz, President and CEO
- Warner Robert Keith, Director
- PALMISANO ROBERT J, Director